Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study

Tyler S. Bryant, Priya Duggal, Bing Yu, Alanna C. Morrison, Tariq Shafi, Georg Ehret, Nora Franceschini, Eric Boerwinkle, Josef Coresh, Adrienne Tin

Research output: Contribution to journalArticle

Abstract

Flavin containing monooxygenase 3 [FMO3] encodes dimethylaniline monooxygenase [N-oxide-forming] 3, which breaks down nitrogen-containing compounds, and has been implicated in blood pressure regulation. Studies have reported conflicting results of the association of a common nonsynonymous variant, E158K (rs2266782), with hypertension. We examined the associations of E158K, along with rare and low frequency exonic variants (minor allele frequency [MAF]<5%) in FMO3 with hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP). We included 7,350 European Americans and 2,814 African Americans in the Atherosclerosis Risk in Communities (ARIC) study with exome sequencing of FMO3. The association of FMO3 variants with SBP and DBP was tested using single variant and gene-based tests followed by the replication or interrogation of significant variants in ancestry-specific cohorts based on Bonferroni corrected thresholds. E158K had significant association with higher SBP in African Americans in ARIC (p=0.03), and two low frequency variants had significant association with higher SBP in African Americans (rs200985584, MAF 0.1%, p=0.0003) and European Americans (rs75904274, MAF 1.7%, p=0.006). These associations were not significant with additional samples: E158K in a meta-Analysis of SBP of African ancestry (N=30,841, p=0.43) that included ARIC participants and the two low frequency variants in an independent ancestry-specific exome sequencing study of blood pressure (rs200985584, p=0.94; rs75904274, p=0.81). Our study does not support the association of E158K and low frequency variants in FMO3 with blood pressure and demonstrates the importance of replication in genetic studies.

Original languageEnglish (US)
Article number2137629
JournalInternational Journal of Hypertension
Volume2019
DOIs
StatePublished - Jan 1 2019

Fingerprint

dimethylaniline monooxygenase (N-oxide forming)
Atherosclerosis
Blood Pressure
Gene Frequency
African Americans
Hypertension
Exome

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study. / Bryant, Tyler S.; Duggal, Priya; Yu, Bing; Morrison, Alanna C.; Shafi, Tariq; Ehret, Georg; Franceschini, Nora; Boerwinkle, Eric; Coresh, Josef; Tin, Adrienne.

In: International Journal of Hypertension, Vol. 2019, 2137629, 01.01.2019.

Research output: Contribution to journalArticle

Bryant, Tyler S. ; Duggal, Priya ; Yu, Bing ; Morrison, Alanna C. ; Shafi, Tariq ; Ehret, Georg ; Franceschini, Nora ; Boerwinkle, Eric ; Coresh, Josef ; Tin, Adrienne. / Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study. In: International Journal of Hypertension. 2019 ; Vol. 2019.
@article{75470720d98741f6804c5f1c31386123,
title = "Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study",
abstract = "Flavin containing monooxygenase 3 [FMO3] encodes dimethylaniline monooxygenase [N-oxide-forming] 3, which breaks down nitrogen-containing compounds, and has been implicated in blood pressure regulation. Studies have reported conflicting results of the association of a common nonsynonymous variant, E158K (rs2266782), with hypertension. We examined the associations of E158K, along with rare and low frequency exonic variants (minor allele frequency [MAF]<5{\%}) in FMO3 with hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP). We included 7,350 European Americans and 2,814 African Americans in the Atherosclerosis Risk in Communities (ARIC) study with exome sequencing of FMO3. The association of FMO3 variants with SBP and DBP was tested using single variant and gene-based tests followed by the replication or interrogation of significant variants in ancestry-specific cohorts based on Bonferroni corrected thresholds. E158K had significant association with higher SBP in African Americans in ARIC (p=0.03), and two low frequency variants had significant association with higher SBP in African Americans (rs200985584, MAF 0.1{\%}, p=0.0003) and European Americans (rs75904274, MAF 1.7{\%}, p=0.006). These associations were not significant with additional samples: E158K in a meta-Analysis of SBP of African ancestry (N=30,841, p=0.43) that included ARIC participants and the two low frequency variants in an independent ancestry-specific exome sequencing study of blood pressure (rs200985584, p=0.94; rs75904274, p=0.81). Our study does not support the association of E158K and low frequency variants in FMO3 with blood pressure and demonstrates the importance of replication in genetic studies.",
author = "Bryant, {Tyler S.} and Priya Duggal and Bing Yu and Morrison, {Alanna C.} and Tariq Shafi and Georg Ehret and Nora Franceschini and Eric Boerwinkle and Josef Coresh and Adrienne Tin",
year = "2019",
month = "1",
day = "1",
doi = "10.1155/2019/2137629",
language = "English (US)",
volume = "2019",
journal = "International Journal of Hypertension",
issn = "2090-0384",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study

AU - Bryant, Tyler S.

AU - Duggal, Priya

AU - Yu, Bing

AU - Morrison, Alanna C.

AU - Shafi, Tariq

AU - Ehret, Georg

AU - Franceschini, Nora

AU - Boerwinkle, Eric

AU - Coresh, Josef

AU - Tin, Adrienne

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Flavin containing monooxygenase 3 [FMO3] encodes dimethylaniline monooxygenase [N-oxide-forming] 3, which breaks down nitrogen-containing compounds, and has been implicated in blood pressure regulation. Studies have reported conflicting results of the association of a common nonsynonymous variant, E158K (rs2266782), with hypertension. We examined the associations of E158K, along with rare and low frequency exonic variants (minor allele frequency [MAF]<5%) in FMO3 with hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP). We included 7,350 European Americans and 2,814 African Americans in the Atherosclerosis Risk in Communities (ARIC) study with exome sequencing of FMO3. The association of FMO3 variants with SBP and DBP was tested using single variant and gene-based tests followed by the replication or interrogation of significant variants in ancestry-specific cohorts based on Bonferroni corrected thresholds. E158K had significant association with higher SBP in African Americans in ARIC (p=0.03), and two low frequency variants had significant association with higher SBP in African Americans (rs200985584, MAF 0.1%, p=0.0003) and European Americans (rs75904274, MAF 1.7%, p=0.006). These associations were not significant with additional samples: E158K in a meta-Analysis of SBP of African ancestry (N=30,841, p=0.43) that included ARIC participants and the two low frequency variants in an independent ancestry-specific exome sequencing study of blood pressure (rs200985584, p=0.94; rs75904274, p=0.81). Our study does not support the association of E158K and low frequency variants in FMO3 with blood pressure and demonstrates the importance of replication in genetic studies.

AB - Flavin containing monooxygenase 3 [FMO3] encodes dimethylaniline monooxygenase [N-oxide-forming] 3, which breaks down nitrogen-containing compounds, and has been implicated in blood pressure regulation. Studies have reported conflicting results of the association of a common nonsynonymous variant, E158K (rs2266782), with hypertension. We examined the associations of E158K, along with rare and low frequency exonic variants (minor allele frequency [MAF]<5%) in FMO3 with hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP). We included 7,350 European Americans and 2,814 African Americans in the Atherosclerosis Risk in Communities (ARIC) study with exome sequencing of FMO3. The association of FMO3 variants with SBP and DBP was tested using single variant and gene-based tests followed by the replication or interrogation of significant variants in ancestry-specific cohorts based on Bonferroni corrected thresholds. E158K had significant association with higher SBP in African Americans in ARIC (p=0.03), and two low frequency variants had significant association with higher SBP in African Americans (rs200985584, MAF 0.1%, p=0.0003) and European Americans (rs75904274, MAF 1.7%, p=0.006). These associations were not significant with additional samples: E158K in a meta-Analysis of SBP of African ancestry (N=30,841, p=0.43) that included ARIC participants and the two low frequency variants in an independent ancestry-specific exome sequencing study of blood pressure (rs200985584, p=0.94; rs75904274, p=0.81). Our study does not support the association of E158K and low frequency variants in FMO3 with blood pressure and demonstrates the importance of replication in genetic studies.

UR - http://www.scopus.com/inward/record.url?scp=85062594771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062594771&partnerID=8YFLogxK

U2 - 10.1155/2019/2137629

DO - 10.1155/2019/2137629

M3 - Article

AN - SCOPUS:85062594771

VL - 2019

JO - International Journal of Hypertension

JF - International Journal of Hypertension

SN - 2090-0384

M1 - 2137629

ER -